2-176123418-C-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_014213.4(HOXD9):c.650C>A(p.Ala217Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000321 in 1,557,056 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014213.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HOXD9 | NM_014213.4 | c.650C>A | p.Ala217Glu | missense_variant | 1/2 | ENST00000249499.8 | NP_055028.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HOXD9 | ENST00000249499.8 | c.650C>A | p.Ala217Glu | missense_variant | 1/2 | 1 | NM_014213.4 | ENSP00000249499.6 | ||
HOXD-AS2 | ENST00000440016.6 | n.498-974G>T | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152196Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000319 AC: 5AN: 156922Hom.: 0 AF XY: 0.0000235 AC XY: 2AN XY: 85112
GnomAD4 exome AF: 0.0000306 AC: 43AN: 1404860Hom.: 0 Cov.: 34 AF XY: 0.0000303 AC XY: 21AN XY: 693722
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152196Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74350
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 04, 2024 | The c.650C>A (p.A217E) alteration is located in exon 1 (coding exon 1) of the HOXD9 gene. This alteration results from a C to A substitution at nucleotide position 650, causing the alanine (A) at amino acid position 217 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at